title: Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?
authors.affiliation: Department of Rheumatology, Immunology and Allergy, Christchurch Hospital, Christchurch, New Zealand.
authors.forename: Ketna
authors.initials: K
authors.lastname: Parekh
authors.forename: Daniel
authors.initials: D
authors.lastname: Ching
authors.forename: Mahboob U
authors.initials: MU
authors.lastname: Rahman
authors.forename: Lisa K
authors.initials: LK
authors.lastname: Stamp
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C529000:golimumab